Bio Rad Laboratories Stock Price Patterns
| BIO Stock | USD 264.55 0.00 0.00% |
Momentum 42
Sell Extended
Oversold | Overbought |
Quarterly Earnings Growth (0.83) | EPS Estimate Next Quarter 2.4671 | EPS Estimate Current Year 10.3061 | EPS Estimate Next Year 10.9844 | Wall Street Target Price 328 |
Using Bio Rad hype-based prediction, you can estimate the value of Bio Rad Laboratories from the perspective of Bio Rad response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Bio Rad using Bio Rad's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Bio using crowd psychology based on the activity and movement of Bio Rad's stock price.
Bio Rad Short Interest
An investor who is long Bio Rad may also wish to track short interest. As short interest increases, investors should be becoming more worried about Bio Rad and may potentially protect profits, hedge Bio Rad with its derivative instruments, or be ready for some potential downside.
200 Day MA 282.04 | Short Percent 0.0427 | Short Ratio 3.69 | Shares Short Prior Month 864.1 K | 50 Day MA 306.3718 |
Bio Rad Laboratories Hype to Price Pattern
Investor biases related to Bio Rad's public news can be used to forecast risks associated with an investment in Bio. The trend in average sentiment can be used to explain how an investor holding Bio can time the market purely based on public headlines and social activities around Bio Rad Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Bio Rad's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Bio Rad.
Bio Rad Implied Volatility | 0.79 |
Bio Rad's implied volatility exposes the market's sentiment of Bio Rad Laboratories stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bio Rad's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bio Rad stock will not fluctuate a lot when Bio Rad's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Bio Rad to buy its stock at a price that has no basis in reality. In that case, they are not buying Bio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bio Rad after-hype prediction price | USD 264.01 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Bio contract
Based on the Rule 16, the options market is currently suggesting that Bio Rad Laboratories will have an average daily up or down price movement of about 0.0494% per day over the life of the 2026-03-20 option contract. With Bio Rad trading at USD 264.55, that is roughly USD 0.13 . If you think that the market is fully incorporating Bio Rad's daily price movement you should consider acquiring Bio Rad Laboratories options at the current volatility level of 0.79%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Bio Rad Basic Forecasting Models to cross-verify your projections. Bio Rad After-Hype Price Density Analysis
As far as predicting the price of Bio Rad at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bio Rad or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bio Rad, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bio Rad Estimiated After-Hype Price Volatility
In the context of predicting Bio Rad's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bio Rad's historical news coverage. Bio Rad's after-hype downside and upside margins for the prediction period are 261.77 and 266.25, respectively. We have considered Bio Rad's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bio Rad is very steady at this time. Analysis and calculation of next after-hype price of Bio Rad Laboratories is based on 3 months time horizon.
Bio Rad Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Bio Rad is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bio Rad backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bio Rad, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 2.25 | 0.59 | 0.20 | 10 Events / Month | 5 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
264.55 | 264.01 | 0.28 |
|
Bio Rad Hype Timeline
On the 17th of February 2026 Bio Rad Laboratories is traded for 264.55. The entity has historical hype elasticity of 0.59, and average elasticity to hype of competition of 0.2. Bio is forecasted to increase in value after the next headline, with the price projected to jump to 264.01 or above. The average volatility of media hype impact on the company the price is about 80.07%. The price boost on the next news is projected to be 0.28%, whereas the daily expected return is currently at -0.21%. The volatility of related hype on Bio Rad is about 234.13%, with the expected price after the next announcement by competition of 264.75. The company reported the last year's revenue of 2.58 B. Total Income to common stockholders was 759.9 M with profit before taxes, overhead, and interest of 1.34 B. Considering the 90-day investment horizon the next forecasted press release will be in about 10 days. Check out Bio Rad Basic Forecasting Models to cross-verify your projections.Bio Rad Related Hype Analysis
Having access to credible news sources related to Bio Rad's direct competition is more important than ever and may enhance your ability to predict Bio Rad's future price movements. Getting to know how Bio Rad's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bio Rad may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GMED | Globus Medical | (1.54) | 8 per month | 1.26 | (0.02) | 3.63 | (2.45) | 7.49 | |
| ALGN | Align Technology | 2.63 | 7 per month | 1.60 | 0.17 | 4.70 | (3.30) | 15.79 | |
| ATR | AptarGroup | 6.64 | 6 per month | 1.11 | 0.15 | 2.93 | (1.51) | 8.45 | |
| HSIC | Henry Schein | 1.89 | 8 per month | 1.45 | 0.03 | 2.43 | (2.60) | 7.52 | |
| GRFS | Grifols SA ADR | 0.06 | 3 per month | 1.66 | 0.04 | 3.23 | (3.28) | 8.28 | |
| HQY | HealthEquity | 1.98 | 9 per month | 0.00 | (0.22) | 2.51 | (4.43) | 12.83 | |
| CRL | Charles River Laboratories | (1.00) | 10 per month | 0.00 | (0.04) | 3.93 | (4.36) | 14.56 | |
| PEN | Penumbra | 0.82 | 9 per month | 1.17 | 0.13 | 3.37 | (1.94) | 16.34 | |
| DVA | DaVita HealthCare Partners | (2.85) | 9 per month | 1.54 | 0.09 | 4.25 | (3.23) | 26.79 | |
| MASI | Masimo | 0.98 | 11 per month | 0.00 | (0.10) | 3.02 | (2.71) | 10.00 |
Bio Rad Additional Predictive Modules
Most predictive techniques to examine Bio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bio using various technical indicators. When you analyze Bio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Bio Rad Predictive Indicators
The successful prediction of Bio Rad stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bio Rad Laboratories, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bio Rad based on analysis of Bio Rad hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bio Rad's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bio Rad's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 66.82 | 64.35 | 66.76 | 86.56 | PTB Ratio | 1.08 | 1.41 | 1.11 | 2.1 |
Pair Trading with Bio Rad
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.Moving together with Bio Stock
| 0.86 | A | Agilent Technologies Earnings Call Tomorrow | PairCorr |
| 0.63 | GSS | Genetic Signatures Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Bio Rad Basic Forecasting Models to cross-verify your projections. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Will Life Sciences Tools & Services sector continue expanding? Could Bio diversify its offerings? Factors like these will boost the valuation of Bio Rad. Projected growth potential of Bio fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bio Rad data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.83) | Earnings Share 27.86 | Revenue Per Share | Quarterly Revenue Growth 0.039 | Return On Assets |
Bio Rad Laboratories's market price often diverges from its book value, the accounting figure shown on Bio's balance sheet. Smart investors calculate Bio Rad's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Bio Rad's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bio Rad's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bio Rad should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.